Global Separation Systems for Commercial Biotechnology Market by Methods (Microarray, Biochip, Lab-on-a-chip, Flow Cytometry, Chromatography) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

In 2016, the global market for commercial separation systems in biotechnology was valued at USD 12.92 million. The biotechnology industry is expected to see significant growth due to rising demand for novel drugs and cell-based therapies.

The field has seen technological advancements. A wide variety of industries can benefit from high throughput and precise cell or molecule sorting methods. The most technologically advanced upstream bioprocessing technology allows for the elimination of biohazardous waste products, reduces equipment size and simplifies processes.

The governments of different countries provide financial assistance to small and medium-sized enterprises in order to implement new technologies. They also develop and execute high-tech strategies to enhance their commercial capabilities. This will drive industrial growth over the next few years.

There have been major advances in traditional methods such as gas chromatography and supercritical fluid chromatography. These techniques allow for the separation of sensitive and large molecules. These methods are used primarily in the pharmaceutical, food processing, and waste management industries. Modern methods such as magnetic separators are also used in the commercial production of plastics and chemicals.

The rising demand for personalized medicine and cell-based therapies, combined with the global shortage of vaccines, are putting new demands on this process. This is driving the adoption of technology-based systems to large-scale downstream bioprocessing. The strong biopharmaceutical pipeline of pharmaceutical companies is facilitating the development of instruments that can be used to purify biomolecules from any debris in large-scale production.

Many industrial players have also entered into strategic partnerships with academic and research institutions. Researchers from Japan recently developed a microfluidic device that is fast and efficient using dual on-chip pumps. These systems are capable of sorting large cells at high speeds with high viability.

Methods Insights

The largest revenue share for separation systems in the commercial biotechnology market is held by conventional methods. Industrial entities have made huge investments in advanced techniques such as flow cytometry or membrane filtration systems for large-scale production. These are just a few of the factors that boost growth.

Modern methods in commercial biotechnology will see the greatest growth. The segment's growth and fulfillment of global industrial demand for bioseparation products market will be accelerated by ongoing investigations.

Application Insights

The largest market share for purification and separation equipment goes to the pharmaceutical industry. The growth of this segment is being driven by a combination of factors such as the existing shortage of vaccines, the rising demand for biotherapies and ongoing research in the area of novel drug development.

In collaboration with industrial partners, research organizations are developing and producing lab-on a chip technology for industrial purposes. This is especially important in the pharmaceutical sector. The market is expected to grow in the future because of the focus on microfluidic devices capable of separating biomolecules.

Regional Insights

North America was the dominant market, especially the U.S. and held the largest revenue share in large-scale separation instruments. The dominance of this market segment is likely due to the presence of local market players, continuous R&D and technological advances in the region.

Asia Pacific will be the fastest-growing region due to the emerging economies of the region, increased R&D spending in the area bioprocessing instruments and government support from China & India. This region is expected to generate revenue due to a rising demand for therapeutics and a global shortage of vaccines.

Researchers from Japan recently developed the microfluidic chips device using dual on-chip pump technology. These high-speed systems are capable of sorting large cells with high viability and high purity. They will also stimulate new separation techniques. These new separators are able to separate small molecules from liquids and gases in a variety of industries, including petrochemical and bioengineering.

The market will be driven by factors like increasing industrialization in developed and developing countries, government support, appropriate strategic framework, and continuous R&D in this field.

Separation Systems for Commercial Biotechnology Market Share insights

The market's major players include Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Shimadzu Corporation, bioMerieux SA, Bio-Rad Laboratories, Inc., Merck & Co., Inc., QIAGEN, WATERS, Sartorius, PerkinElmer, Inc., Miltenyi Biotec, and BD.

Major players in the industry are currently forming strategic partnerships and working together to improve their product portfolios in separation systems. This will enable them to create technologically advanced downstream processing system.

Separation Systems for Commercial Biotechnology Market Report Scope

The Report Covers Certain Segments

This report predicts revenue growth at both the country and regional level. It also provides analysis of the most recent trends and opportunities in each sub-segment from 2014 through 2025. Grand View Research divided the commercial biotechnology market for separation systems on the basis of method, application and region.

• Method Outlook (Revenue USD Million; 2014-2025)

  • Modern methods

    • Microarray

    • Lab-on-a Chip

    • Biochip

    • Magnetic separation

  • Conventional methods

    • Chromatography

    • Flow Cytometry

    • Membrane filtration

    • Electrophoresis

    • Centrifugation

• App Outlook (Revenue USD Million; 2014-2025)

  • Pharmaceutical

    • Vaccines

    • Proteins

    • Hormones/Insulin

    • Enzymes

    • Human Blood Plasma Fractionation

    • Mammalian Cell Cultures

  • Food & Cosmetics

  • Agriculture

  • Other

• Regional Outlook (Revenue USD Million; 2014-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • India

  • Latin America

    • Brazil

  • The Middle East and Africa (MEA).

    • South Africa

These are the most frequently asked questions about this report

b. Global market for separation systems in commercial biotechnology was valued at USD 19.02 Billion in 2019, and is forecast to grow to USD 21.57 Billion by 2020.

b. Global separation systems for commercial biotechnology will grow at 12.9% compound annual growth rate from 2020-2025, to reach USD 39.47 Billion by 2025.

b. North America dominated the separation systems for commercial biotechnology market with a share of 31.7% in 2019 owing to the well-established biotechnology industry in the U.S. and presence of a substantial number of biotechnology-focused companies in the region.

b. b.

b. The market growth is driven by the expansion of biopharmaceuticals pipeline program, rising global funding for biotechnology research programs and the entry of new players.

Up Market Research published a new report titled “Separation Systems for Commercial Biotechnology Market research report which is segmented by Methods (Microarray, Biochip, Lab-on-a-chip, Flow Cytometry, Chromatography), By Players/Companies Inc; QIAGEN; WATERS; Sartorius; PerkinElmer, Inc; Hitachi Koki Co, Inc; Danaher; Miltenyi Biotec; and BD, Thermo Fisher Scientific; GE Healthcare; Agilent Technologies; Shimadzu Corporation; bioM©rieux SA; Bio-Rad Laboratories, Ltd; Merck & Co”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Separation Systems for Commercial Biotechnology Market Report Segments:

The market is segmented by Methods (Microarray, Biochip, Lab-on-a-chip, Flow Cytometry, Chromatography).

Separation Systems for Commercial Biotechnology Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Separation Systems for Commercial Biotechnology Market

Overview of the regional outlook of the Separation Systems for Commercial Biotechnology Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Separation Systems for Commercial Biotechnology Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Separation Systems for Commercial Biotechnology Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Microarray

                2. Biochip

                3. Lab-on-a-chip

                4. Flow Cytometry

                5. Chromatography

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Separation Systems for Commercial Biotechnology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Separation Systems for Commercial Biotechnology Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.